New Brunswick's Review of Mystery Neurological Illness Faces Criticism Over Transparency
Families of affected patients question the impartiality of the review, citing the involvement of officials from the initial investigation and the dismissal of a key neurologist.
- The New Brunswick government is reviewing 222 cases of a potential mystery neurological illness in collaboration with the Public Health Agency of Canada, with findings expected by summer 2025.
- The illness, characterized by symptoms such as pain, seizures, and confusion, has reportedly affected over 400 individuals since the initial 2021 investigation was closed without conclusive results.
- Families, including the Beatty siblings, have expressed skepticism about the review, calling for an independent scientific investigation free from the influence of officials involved in the 2021 inquiry.
- Chief medical officer Dr. Yves Léger stated the review will focus on analyzing patient files and testing methods to identify potential environmental exposures.
- The dismissal of neurologist Dr. Allier Marrero, who had been treating many affected patients, has intensified criticism of the government’s handling of the investigation.
The Globe and Mail 
Global News 